{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:35:24Z","timestamp":1790307324576,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"South-Eastern Norway Regional Health Authrities","award":["2019071"],"award-info":[{"award-number":["2019071"]}]},{"name":"South-Eastern Norway Regional Health Authrities","award":["2019071"],"award-info":[{"award-number":["2019071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98689-3","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:15:29Z","timestamp":1745496929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification and evaluation of Pharmacological enhancers of the factor VII p.Q160R variant"],"prefix":"10.1038","volume":"15","author":[{"given":"M. S.","family":"Andresen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Mowinckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Skarpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Chollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"98689_CR1","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1073\/pnas.83.8.2412","volume":"83","author":"F S Hagen","year":"1986","unstructured":"S Hagen, F. et al. Characterization of a cDNA coding for human factor VII. Proc. Natl. Acad. Sci. U S A. 83, 2412\u20132416. https:\/\/doi.org\/10.1073\/pnas.83.8.2412 (1986).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"98689_CR2","doi-asserted-by":"publisher","unstructured":"Rao, L. V. & Rapaport, S. I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 85, 6687\u20136691, (1988). https:\/\/doi.org\/10.1073\/pnas.85.18.6687","DOI":"10.1073\/pnas.85.18.6687"},{"key":"98689_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1179\/102453311x13085644680069","volume":"16","author":"A Girolami","year":"2011","unstructured":"Girolami, A., Bertozzi, I., de Marinis, G. B., Bonamigo, E. & Fabris, F. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. Hematology 16, 308\u2013312. https:\/\/doi.org\/10.1179\/102453311x13085644680069 (2011).","journal-title":"Hematology"},{"key":"98689_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","volume":"125","author":"R Palla","year":"2015","unstructured":"Palla, R., Peyvandi, F. & Shapiro, A. D. Rare bleeding disorders: diagnosis and treatment. Blood 125, 2052\u20132061. https:\/\/doi.org\/10.1182\/blood-2014-08-532820 (2015).","journal-title":"Blood"},{"key":"98689_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0029-1225762","volume":"35","author":"G Mariani","year":"2009","unstructured":"Mariani, G., Bernardi, F., Factor, V. I. I. & Deficiency Semin Thromb. Hemost. 35, 400\u2013406, doi:https:\/\/doi.org\/10.1055\/s-0029-1225762 (2009).","journal-title":"Semin Thromb. Hemost."},{"key":"98689_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2141.2002.03545.x","volume":"118","author":"DJ Perry","year":"2002","unstructured":"Perry, D. J., Factor, V. I. I. & Deficiency Br. J. Haematol. 118, 689\u2013700, doi:https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03545.x (2002).","journal-title":"Br. J. Haematol."},{"key":"98689_CR7","doi-asserted-by":"publisher","unstructured":"Borhany, M. et al. Bleeding disorders in the tribe: result of consanguineous in breeding. Orphanet J. Rare Dis. 5 https:\/\/doi.org\/10.1186\/1750-1172-5-23 (2010).","DOI":"10.1186\/1750-1172-5-23"},{"key":"98689_CR8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1788792","author":"F Bernardi","year":"2024","unstructured":"Bernardi, F., Mariani, G. & Clinical Laboratory, and molecular aspects of factor VII deficiency. Semin Thromb. Hemost. https:\/\/doi.org\/10.1055\/s-0044-1788792 (2024).","journal-title":"Semin Thromb. Hemost."},{"key":"98689_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1098-1004(2001)17:1<3::AID-HUMU2>3.0.CO;2-V","volume":"17","author":"JH McVey","year":"2001","unstructured":"McVey, J. H., Boswell, E., Mumford, A. D., Kemball-Cook, G. & Tuddenham, E. G. Factor VII deficiency and the FVII mutation database. Hum. Mutat. 17, 3\u201317. https:\/\/doi.org\/10.1002\/1098-1004(2001)17:1<3::AID-HUMU2>3.0.CO;2-V (2001).","journal-title":"Hum. Mutat."},{"key":"98689_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1055\/s-0037-1615030","volume":"79","author":"A Kavlie","year":"1998","unstructured":"Kavlie, A., Orning, L., Grindflek, A., Stormorken, H. & Prydz, H. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain. Thromb. Haemost. 79, 1136\u20131143 (1998).","journal-title":"Thromb. Haemost"},{"key":"98689_CR11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1182\/blood.V93.4.1237","volume":"93","author":"M Hunault","year":"1999","unstructured":"Hunault, M., Arbini, A. A., Carew, J. A., Peyvandi, F. & Bauer, K. A. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII. Blood 93, 1237\u20131244 (1999).","journal-title":"Blood"},{"key":"98689_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1055\/s-0038-1637690","volume":"118","author":"E Andersen","year":"2018","unstructured":"Andersen, E. et al. Activation of Endoplasmic reticulum stress and unfolded protein response in congenital factor VII deficiency. Thromb. Haemost. 118, 664\u2013675. https:\/\/doi.org\/10.1055\/s-0038-1637690 (2018).","journal-title":"Thromb. Haemost"},{"key":"98689_CR13","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.273.14.8516","volume":"273","author":"G Kemball-Cook","year":"1998","unstructured":"Kemball-Cook, G. et al. Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function. J. Biol. Chem. 273, 8516\u20138521. https:\/\/doi.org\/10.1074\/jbc.273.14.8516 (1998).","journal-title":"J. Biol. Chem."},{"key":"98689_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3324\/haematol.2020.248542","volume":"106","author":"F Bernardi","year":"2021","unstructured":"Bernardi, F. & Mariani, G. Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis. Haematologica 106, 351\u2013362. https:\/\/doi.org\/10.3324\/haematol.2020.248542 (2021).","journal-title":"Haematologica"},{"key":"98689_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1186\/s12913-022-08272-z","volume":"22","author":"N Krishnamurthy","year":"2022","unstructured":"Krishnamurthy, N., Grimshaw, A. A., Axson, S. A., Choe, S. H. & Miller, J. E. Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Serv. Res. 22, 970. https:\/\/doi.org\/10.1186\/s12913-022-08272-z (2022).","journal-title":"BMC Health Serv. Res."},{"key":"98689_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168 (2019).","journal-title":"Nat. Rev. Drug Discov"},{"key":"98689_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468 (2004).","journal-title":"Nat. Rev. Drug Discov"},{"key":"98689_CR18","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.4238\/2013.December.16.7","volume":"12","author":"W Xiao","year":"2013","unstructured":"Xiao, W., Li, C. Q., Xiao, X. P. & Lin, F. Z. Expression and fast Preparation of biologically active Recombinant human coagulation factor VII in CHO-K1 cells. Genet. Mol. Res. 12, 6813\u20136824. https:\/\/doi.org\/10.4238\/2013.December.16.7 (2013).","journal-title":"Genet. Mol. Res."},{"key":"98689_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/21655979.2016.1176656","volume":"7","author":"L Peng","year":"2016","unstructured":"Peng, L. et al. Enhanced Recombinant factor VII expression in Chinese hamster ovary cells by optimizing signal peptides and fed-batch medium. Bioengineered 7, 189\u2013197. https:\/\/doi.org\/10.1080\/21655979.2016.1176656 (2016).","journal-title":"Bioengineered"},{"key":"98689_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12896-015-0205-1","volume":"15","author":"E B\u00f6hm","year":"2015","unstructured":"B\u00f6hm, E. et al. Differences in N-glycosylation of Recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnol. 15, 87. https:\/\/doi.org\/10.1186\/s12896-015-0205-1 (2015).","journal-title":"BMC Biotechnol."},{"key":"98689_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1200\/jco.2016.70.5350","volume":"35","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal, R. et al. Inhibiting histone deacetylase as a means to reverse resistance to angiogenesis inhibitors: phase I study of abexinostat plus pazopanib in advanced solid tumor malignancies. J. Clin. Oncol. 35, 1231\u20131239. https:\/\/doi.org\/10.1200\/jco.2016.70.5350 (2017).","journal-title":"J. Clin. Oncol."},{"key":"98689_CR22","doi-asserted-by":"publisher","first-page":"1164514","DOI":"10.3389\/fimmu.2023.1164514","volume":"14","author":"B Lian","year":"2023","unstructured":"Lian, B., Chen, X. & Shen, K. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer. Front. Immunol. 14, 1164514. https:\/\/doi.org\/10.3389\/fimmu.2023.1164514 (2023).","journal-title":"Front. Immunol."},{"key":"98689_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3324\/haematol.2016.154377","volume":"102","author":"V Ribrag","year":"2017","unstructured":"Ribrag, V. et al. Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study. Haematologica 102, 903\u2013909. https:\/\/doi.org\/10.3324\/haematol.2016.154377 (2017).","journal-title":"Haematologica"},{"key":"98689_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bioorg.2016.05.005","volume":"67","author":"M Manal","year":"2016","unstructured":"Manal, M., Chandrasekar, M. J., Gomathi Priya, J. & Nanjan, M. J. Inhibitors of histone deacetylase as antitumor agents: A critical review. Bioorg. Chem. 67, 18\u201342. https:\/\/doi.org\/10.1016\/j.bioorg.2016.05.005 (2016).","journal-title":"Bioorg. Chem."},{"key":"98689_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbagrm.2010.06.003","volume":"1799","author":"M Lawson","year":"2010","unstructured":"Lawson, M. et al. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). Biochim. Biophys. Acta. 1799, 726\u2013739. https:\/\/doi.org\/10.1016\/j.bbagrm.2010.06.003 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"98689_CR26","doi-asserted-by":"publisher","first-page":"e0156999","DOI":"10.1371\/journal.pone.0156999","volume":"11","author":"M Koppitz","year":"2016","unstructured":"Koppitz, M. et al. Mucolytic effectiveness of tyloxapol in chronic obstructive pulmonary Disease - A Double-Blind, randomized controlled trial. PLoS One. 11, e0156999. https:\/\/doi.org\/10.1371\/journal.pone.0156999 (2016).","journal-title":"PLoS One"},{"key":"98689_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s10517-013-2133-1","volume":"155","author":"VM Loginova","year":"2013","unstructured":"Loginova, V. M., Tuzikov, F. V., Tuzikova, N. A. & Korolenko, T. A. Comparative characteristics of lipemia models induced by injections of Triton WR-1339 and poloxamer 407 in mice. Bull. Exp. Biol. Med. 155, 284\u2013287. https:\/\/doi.org\/10.1007\/s10517-013-2133-1 (2013).","journal-title":"Bull. Exp. Biol. Med."},{"key":"98689_CR28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10517-010-0994-0","volume":"149","author":"TA Korolenko","year":"2010","unstructured":"Korolenko, T. A., Tuzikov, F. V., Vasil\u2019eva, E. D., Cherkanova, M. S. & Tuzikova, N. A. Fractional composition of blood serum lipoproteins in mice and rats with Triton WR 1339-induced lipemia. Bull. Exp. Biol. Med. 149, 567\u2013570. https:\/\/doi.org\/10.1007\/s10517-010-0994-0 (2010).","journal-title":"Bull. Exp. Biol. Med."},{"key":"98689_CR29","doi-asserted-by":"publisher","first-page":"13080","DOI":"10.1021\/acs.jafc.1c05213","volume":"69","author":"M Jin","year":"2021","unstructured":"Jin, M. et al. Erythritol improves nonalcoholic fatty liver disease by activating Nrf2 antioxidant capacity. J. Agric. Food Chem. 69, 13080\u201313092. https:\/\/doi.org\/10.1021\/acs.jafc.1c05213 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"98689_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13578-019-0333-8","volume":"9","author":"E Andersen","year":"2019","unstructured":"Andersen, E. et al. The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII. Cell. Biosci. 9, 69. https:\/\/doi.org\/10.1186\/s13578-019-0333-8 (2019).","journal-title":"Cell. Biosci."},{"key":"98689_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fcell.2019.00131","volume":"7","author":"E Ahat","year":"2019","unstructured":"Ahat, E., Li, J. & Wang, Y. New insights into the golgi stacking proteins. Front. Cell. Dev. Biology. 7, 131. https:\/\/doi.org\/10.3389\/fcell.2019.00131 (2019).","journal-title":"Front. Cell. Dev. Biology"},{"key":"98689_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.tibs.2020.08.001","volume":"45","author":"X Zhang","year":"2020","unstructured":"Zhang, X. & Wang, Y. Nonredundant roles of GRASP55 and GRASP65 in the golgi apparatus and beyond. Trends Biochem. Sci. 45, 1065\u20131079. https:\/\/doi.org\/10.1016\/j.tibs.2020.08.001 (2020).","journal-title":"Trends Biochem. Sci."},{"key":"98689_CR33","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.1093\/emboj\/19.23.6427","volume":"19","author":"A Kuo","year":"2000","unstructured":"Kuo, A., Zhong, C., Lane, W. S. & Derynck, R. Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, golgi membrane-associated protein p59\/GRASP55. EMBO J. 19, 6427\u20136439. https:\/\/doi.org\/10.1093\/emboj\/19.23.6427 (2000).","journal-title":"EMBO J."},{"key":"98689_CR34","doi-asserted-by":"publisher","first-page":"34849","DOI":"10.1074\/jbc.M109.068403","volume":"284","author":"G D\u2019Angelo","year":"2009","unstructured":"D\u2019Angelo, G. et al. GRASP65 and GRASP55 sequentially promote the transport of C-terminal valine-bearing cargos to and through the golgi complex. J. Biol. Chem. 284, 34849\u201334860. https:\/\/doi.org\/10.1074\/jbc.M109.068403 (2009).","journal-title":"J. Biol. Chem."},{"key":"98689_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2015.02.057","volume":"459","author":"MF Stein","year":"2015","unstructured":"Stein, M. F. et al. CD83 and GRASP55 interact in human dendritic cells. Biochem. Biophys. Res. Commun. 459, 42\u201348. https:\/\/doi.org\/10.1016\/j.bbrc.2015.02.057 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98689_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cell.2011.07.021","volume":"146","author":"HY Gee","year":"2011","unstructured":"Gee, H. Y., Noh, S. H., Tang, B. L., Kim, K. H. & Lee, M. G. Rescue of \u2206F508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway. Cell 146, 746\u2013760. https:\/\/doi.org\/10.1016\/j.cell.2011.07.021 (2011).","journal-title":"Cell"},{"key":"98689_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen, J. T. et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat. 37, 564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981 (2016).","journal-title":"Hum. Mutat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98689-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98689-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98689-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:15:30Z","timestamp":1745496930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98689-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98689"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98689-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14315"}}